FDA approves Benralizumab as Add-On Maintenance Therapy for kids aged 6 to 11 with severe asthma Dr. Kamal Kant Kohli15 April 2024 6:45 AM ISTAstraZeneca's FASENRA® (benralizumab) is now approved by the US Food and Drug Administration (FDA) for add-on maintenance treatment for patients with...
AstraZeneca, Daiichi Sankyo Datopotamab deruxtecan application accepted in US for pretreated metastatic HR-positive, HER2-negative breast cancer Ruchika Sharma3 April 2024 12:30 PM ISTAstraZeneca and Daiichi Sankyo's Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted in the US for the...
USFDA nod to Voydeya as add on therapy to ravulizumab or eculizumab for extravascular haemolysis in adults with rare disease PNH: AstraZeneca Ruchika Sharma1 April 2024 3:18 PM ISTCambridge: AstraZeneca has announced that Voydeya (danicopan) has been approved in the US as add-on therapy to ravulizumab or eculizumab for the...
AstraZeneca Truqap plus Faslodex gets nod in Japan for advanced HR-positive breast cancer Ruchika Sharma31 March 2024 2:30 PM ISTCambridge: AstraZeneca's Truqap (capivasertib) in combination with Faslodex (fulvestrant) has been approved in Japan for the treatment of adult...
AstraZeneca-Sanofi Beyfortus approved in Japan for prevention of RSV disease in infants Ruchika Sharma31 March 2024 12:30 PM ISTCambridge: AstraZeneca and Sanofi's Beyfortus (nirsevimab), a long-acting monoclonal antibody, has been approved in Japan for the prophylaxis of...
AstraZeneca India bags dual CDSCO nod for Trastuzumab deruxtecan Ruchika Sharma28 March 2024 1:30 PM ISTBangalore: AstraZeneca Pharma India Limited has received permission to import for sale and distribution of Trastuzumab deruxtecan lyophilized...
AstraZeneca to acquire Fusion Pharma to accelerate development of next-generation radioconjugates to treat cancer Susmita Roy19 March 2024 4:11 PM ISTCambridge: AstraZeneca has entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company...
AstraZeneca Gets CDSCO Panel Nod to Study anticancer drug Volrustomig Dr. Divya Colin17 March 2024 6:00 PM ISTNew Delhi: The drug major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
AstraZeneca to acquire Amolyt Pharma for USD 1.05 billion Susmita Roy15 March 2024 2:17 PM ISTCambridge: AstraZeneca has announced that it has entered into a definitive agreement to acquire Amolyt Pharma, a clinical-stage biotechnology...
AstraZeneca gets CDSCO Panel Nod To Import, Market Sodium Zirconium Cyclosilicate Powder for Oral Suspension Dr. Divya Colin9 March 2024 6:00 PM ISTNew Delhi: Noting an unmet medical need, the Subject ExperCommittee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has...
AstraZeneca gets CDSCO Panel Nod To update Prescribing Information of Antidiabetic FDC Dr. Divya Colin7 March 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to...
EMA validates marketing authorisation applications for AstraZeneca, Daiichi Sankyo datopotamab deruxtecan in lung, breast cancer Ruchika Sharma6 March 2024 3:25 PM ISTCambridge: The European Medicines Agency (EMA) has validated two marketing authorisation applications (MAAs) for AstraZeneca and Daiichi Sankyo’s...
